The Top Three Holders Of Exelixis, Inc. (EXEL)

Exelixis, Inc. (NASDAQ:EXEL) reached 16.97% versus a 1-year low price of $18.03. The stock was last seen -1.54% lower, reaching at $21.09 on 04/19/2018. At recent session, the prices were hovering between $20.83 and $21.37. This company shares are 67.33% off its target price of $35.29 and the current market capitalization stands at $6.37B. The recent change has given its price a -14.87% deficit over SMA 50 and -35.11% deficit over its 52-week high. The stock witnessed -13.95% declines, -24.3% declines and -25.48% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found EXEL’s volatility during a week at 3.79% and during a month it has been found around 4.85%.

Exelixis, Inc. (EXEL) Top Holders

Institutional investors currently hold around $5.12 billion or 82% in EXEL stock. Look at its top three institutional owners. Fmr Llc owns $780.53 million in Exelixis, Inc., which represents roughly 12.25% of the company’s market cap and approximately 15.26% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 26,351,871 shares of the stock are valued at $564.46 million. The third largest holder is Meditor Group Ltd, which currently holds $353.1 million worth of this stock and that ownership represents nearly 5.54% of its market capitalization.

Exelixis, Inc. 13F Filings

At the end of 12/31/2017 reporting period, 171 institutional holders increased their position in Exelixis, Inc. (NASDAQ:EXEL) by some 21,512,126 shares, 118 decreased positions by 24,921,349 and 41 held positions by 192,397,337. That puts total institutional holdings at 238,830,812 shares, according to SEC filings. The stock grabbed 67 new institutional investments totaling 5,048,678 shares while 32 institutional investors sold out their entire positions totaling 2,313,247 shares.

Exelixis, Inc. (NASDAQ:EXEL) Insider Trades

Multiple company employees have indulged in significant insider trading. Exelixis, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Garber Alan M has sold 15,000 shares of Exelixis, Inc. (EXEL) in trading session dated Apr. 16, 2018. These shares are worth $303,750 and were traded at $20.25 each. The SEC filing shows that Wyszomierski Jack L performed a sale of 14,959 shares. The Director disposed these shares by way of transaction on Apr. 16, 2018. The company’s shares were given away at $20.25 per share worth to an income of some $302,920 on account of Wyszomierski Jack L.

President and CEO, Morrissey Michael, sold 90,000 common shares of Exelixis, Inc. (EXEL) in the open market. In a transaction dated Apr. 11, 2018, the shares were put up for sale at an average price of $20.78, raking in a sum of $1,870,200. After this sale, 318,604 common shares of EXEL are directly owned by the insider, with total stake valued at $6,719,358.

In the transaction dated Mar. 06, 2018, the great number of shares disposed came courtesy the Director; Marchesi Vincent T disposed a total of 15,000 shares at an average price of $24.73, amounting to approximately $370,950. The insider now directly owns 125,913 shares worth $2,655,505.

Exelixis, Inc. (EXEL) Analyst Guide

Several analysts have released their opinion on Exelixis, Inc. (NASDAQ:EXEL), with 5 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.63 average brokerage recommendation.

SHARE
Previous articleWhich insiders are selling Immunomedics, Inc. (IMMU)?
Next articleHeadfake or Buy the Momentum Noble Corporation plc (NE), vTv Therapeutics Inc. (VTVT)